CytomX Therapeutics (CTMX) FCF Margin (2014 - 2026)
CytomX Therapeutics (CTMX) posted FCF Margin of -1274.19% for Q2 2026, down 1189.61 percentage points from -84.57% a year earlier and down 1025.12 percentage points from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) FCF Margin (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at CytomX Therapeutics was -450.67%, down 395.62 percentage points year-over-year; for FY2025, it was -99.48%, down 36.82 percentage points from FY2024.
- Annual FCF Margin shows a five-year change of -103.79 percentage points (FY2020 to FY2025).
- In prior years, CytomX Therapeutics' FCF Margin was -62.66% in FY2024 (-6.47 pp), -56.19% in FY2023 (+155.47 pp), -211.67% in FY2022 (+111.66 pp) and -323.33% in FY2021 (-327.64 pp).
- Quarterly FCF Margin has run from a low of -3536.05% in Q4 2025 to a high of 39.58% in Q1 2023 over five years.
- On a year-over-year basis, FCF Margin has declined in each of the last five quarters, with an average year-over-year change of -627.98 percentage points over the last eight quarters.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q1 2023, with a gain of 504.72 percentage points; the weakest was Q4 2025, with a drop of 3483.58 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -249.06% (Q1 2026), -3536.05% (Q4 2025) and -258.61% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | CytomX Therapeutics | 586.15 Mn | -371.52 Mn | - | -1,274.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,274.19% |
| Mar 31, 2026 | -249.06% |
| Dec 31, 2025 | -3,536.05% |
| Sep 30, 2025 | -258.61% |
| Jun 30, 2025 | -84.57% |
| Mar 31, 2025 | -41.56% |
| Dec 31, 2024 | -52.47% |
| Sep 30, 2024 | -62.06% |
| Jun 30, 2024 | -78.22% |
| Mar 31, 2024 | -63.09% |
| Dec 31, 2023 | -83.55% |
| Sep 30, 2023 | -69.18% |
| Jun 30, 2023 | -103.93% |
| Mar 31, 2023 | 39.58% |
| Dec 31, 2022 | -7.83% |
| Sep 30, 2022 | -307.30% |
| Jun 30, 2022 | -269.58% |
| Mar 31, 2022 | -465.14% |
| Dec 31, 2021 | -282.40% |
| Sep 30, 2021 | -326.13% |
API Access
CytomX Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();